Comparison between antifibrinolytic and antiprostaglandin treatment in the reduction of increased menstrual blood loss in women with intrauterine contraceptive devices-Reference-Cited by-同舟云学术

Comparison between antifibrinolytic and antiprostaglandin treatment in the reduction of increased menstrual blood loss in women with intrauterine contraceptive devices

Published:1983-01 Issue:1 Volume:90 Page:78-83
ISSN:1470-0328
Container-title:BJOG: An International Journal of Obstetrics and Gynaecology
language:en
Short-container-title:BJOG:An international journal of O&G

Author:

YLIKORKALA OLAVI,VIINIKKA LASSE

Publisher

Wiley

Subject

Obstetrics and Gynecology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1471-0528.1983.tb06751.x/fullpdf

Reference30 articles.

1. Differential production of prostaglandins within the human uterus

2. REDUCTION OF MENSTRUAL BLOOD-LOSS BY PROSTAGLANDIN-SYNTHETASE INHIBITORS

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. U.S. Selected Practice Recommendations for Contraceptive Use, 2024;MMWR. Recommendations and Reports;2024-08-08

2. Interventions to prevent or treat heavy menstrual bleeding or pain associated with intrauterine-device use;Cochrane Database of Systematic Reviews;2022-08-26

3. Follow-Up After IUD Insertions: Managing IUD Expectations, Addressing Side Effects, and Providing Post-Insertion Counseling;Optimizing IUD Delivery for Adolescents and Young Adults;2019

4. Oral micronised flavonoids versus tranexamic acid for treatment of heavy menstrual bleeding secondary to copper IUD use: a randomised double-blind clinical trial;The European Journal of Contraception & Reproductive Health Care;2018-09-03

5. Antifibrinolytics for heavy menstrual bleeding;Cochrane Database of Systematic Reviews;2018-04-15